Shell-mediated phagocytosis to reshape viral-vectored vaccine-induced immunity-Reference-Cited by-同舟云学术

Shell-mediated phagocytosis to reshape viral-vectored vaccine-induced immunity

Published:2021-09 Issue: Volume:276 Page:121062
ISSN:0142-9612
Container-title:Biomaterials
language:en
Short-container-title:Biomaterials

Author:

Feng Fengling^ORCID,Hao Haibin,Zhao Jin,Li Yanjun,Zhang Ying,Li Ruiting,Wen Ziyu,Wu Chunxiu,Li Minchao,Li Pingchao,Chen Ling,Tang Ruikang,Wang Xiaoyu,Sun Caijun

Funder

Natural Science Foundation of Guangdong Province

National Major Science and Technology Projects of China

Science and Technology Planning Project of Shenzhen Municipality

National Institutes of Health

China Postdoctoral Science Foundation

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Mechanics of Materials,Biomaterials,Biophysics,Ceramics and Composites,Bioengineering

Reference56 articles.

1. Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia;Logunov;Lancet,2020

2. Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial;Zhu;Lancet,2020

3. Safety and immunogenicity of a recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in Sierra Leone: a single-centre, randomised, double-blind, placebo-controlled, phase 2 trial;Zhu;Lancet,2017

4. Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19);Barouch;Lancet,2018

5. Safety and immunogenicity of an oral, replicating adenovirus serotype 4 vector vaccine for H5N1 influenza: a randomised, double-blind, placebo-controlled, phase 1 study;Gurwith;Lancet Infect. Dis.,2013

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Programming Myeloid Cells with Chimeric Antigen Receptor Myeloid‐Based Therapies;Precision Cancer Therapies vol 2 ‐ Immunologic Approaches for the Treatment of Lymphoid Malignancies ‐ From Concept to Practice;2024-02-21

2. The 2 ^nd China Vaccinology Integrated Innovation & Teaching Development Conference: Promoting the construction of vaccinology discipline system;Human Vaccines & Immunotherapeutics;2024-01-10

3. Nanovaccines for Advancing Long-Lasting Immunity against Infectious Diseases;ACS Nano;2023-12-06

4. Oral delivery of a chitosan adjuvanted COVID-19 vaccine provides long-lasting and broad-spectrum protection against SARS-CoV-2 variants of concern in golden hamsters;Antiviral Research;2023-12

5. Rapid Induction of Long-Lasting Systemic and Mucosal Immunity via Thermostable Microneedle-Mediated Chitosan Oligosaccharide-Encapsulated DNA Nanoparticles;ACS Nano;2023-11-22